15.05.2015 Views

Swiss DolorClast ® Brochure - Ortho Providers

Swiss DolorClast ® Brochure - Ortho Providers

Swiss DolorClast ® Brochure - Ortho Providers

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

EXTRA-<br />

CORPOREAL<br />

SHOCKWAVE<br />

THERAPY


<strong>Swiss</strong> <strong>DolorClast</strong> ® - FDA Class III Approved.


<strong>Swiss</strong> <strong>DolorClast</strong> ® - FDA Class III Approved.


Substance P plays a central role as a pain-mediator and growth factor.<br />

> Shockwaves lead to depletion of substance P out of its storing vesicles.<br />

> This molecular mechanism explains the long lasting analgesic effect of shockwaves.<br />

Furthermore, substance P has been shown to dilate blood vessels, stimulate neovascularization<br />

and contribute to new bone formation.<br />

<br />

> Shock waves stimulate the early expression of angiogenesis related growth factors including<br />

eNOS (endothelial nitric oxide synthase), VEGF (vessel endothelial growth factor) and PCNA<br />

(proliferating cell nuclear antigen). This promotes neovascularisation that improves blood supply<br />

and increases cell proliferation and tissue regeneration to repair tendon or bone tissues.<br />

<br />

> Scientific studies show that shockwaves, and the overstimulating of small nerve fibers, block an<br />

increase in pain stimuli and thus intensify the analgesic effect (Melzak and Wall, Gate Control Theory).<br />

<br />

<br />

<br />

Scientific Background<br />

1. Hausdorf J, Schmitz C, Averbeck B, Maier M. - Molecular basis for pain mediating properties of extracorporeal shock waves<br />

Schmerz. 2004 Dec;18(6):492-7. German.<br />

2. Maier M, Averbeck B, Milz S, Refior HJ, Schmitz C. - Substance P and prostaglandin E2 release after shock wave application to the rabbit femur.<br />

Clin <strong>Ortho</strong>p Relat Res. 2003 Jan;(406):237-45.<br />

3. Wang CJ. - An overview of shock wave therapy in musculoskeletal disorders.<br />

Chang Gung Med J. 2003 Apr;26(4):220-32. Review.


Substance P plays a central role as a pain-mediator and growth factor.<br />

> Shockwaves lead to depletion of substance P out of its storing vesicles.<br />

> This molecular mechanism explains the long lasting analgesic effect of shockwaves.<br />

Furthermore, substance P has been shown to dilate blood vessels, stimulate neovascularization<br />

and contribute to new bone formation.<br />

<br />

> Shock waves stimulate the early expression of angiogenesis related growth factors including<br />

eNOS (endothelial nitric oxide synthase), VEGF (vessel endothelial growth factor) and PCNA<br />

(proliferating cell nuclear antigen). This promotes neovascularisation that improves blood supply<br />

and increases cell proliferation and tissue regeneration to repair tendon or bone tissues.<br />

<br />

> Scientific studies show that shockwaves, and the overstimulating of small nerve fibers, block an<br />

increase in pain stimuli and thus intensify the analgesic effect (Melzak and Wall, Gate Control Theory).<br />

<br />

<br />

<br />

Scientific Background<br />

1. Hausdorf J, Schmitz C, Averbeck B, Maier M. - Molecular basis for pain mediating properties of extracorporeal shock waves<br />

Schmerz. 2004 Dec;18(6):492-7. German.<br />

2. Maier M, Averbeck B, Milz S, Refior HJ, Schmitz C. - Substance P and prostaglandin E2 release after shock wave application to the rabbit femur.<br />

Clin <strong>Ortho</strong>p Relat Res. 2003 Jan;(406):237-45.<br />

3. Wang CJ. - An overview of shock wave therapy in musculoskeletal disorders.<br />

Chang Gung Med J. 2003 Apr;26(4):220-32. Review.


Kinetic energy is converted into impact energy,<br />

as illustrated by Newton’s Cradle.


The advantage of extracorporeal shockwaves is that<br />

they produce an analgesic effect on the treated area.<br />

The unfocused propagation of the shockwaves extends<br />

to the entire area where pain occurs.


The advantage of extracorporeal shockwaves is that<br />

they produce an analgesic effect on the treated area.<br />

The unfocused propagation of the shockwaves extends<br />

to the entire area where pain occurs.


1. Locating the area of pain by palpation 2. Marking the treatment area<br />

3. Applying the contact gel 4. Delivering the shockwaves


1. Locating the area of pain by palpation 2. Marking the treatment area<br />

3. Applying the contact gel 4. Delivering the shockwaves


Heel pain is a “catch-all term” for any condition that can occur around the heel. The most common<br />

of these conditions is known as PLANTAR FASCIITIS. The plantar fascia (PF) is a strong ligament (tensile<br />

strength of 4000 lbs/sq. inch) that is located along the under surface of the foot, extending from the base of<br />

the toes to the heel bone (calcaneus). The PF is almost as wide as the foot and plays an important role in<br />

support of the foot as well as function.<br />

> When the plantar fascia is strained due to overuse, improper shoes, or abnormal foot structure, it can<br />

initially become irritated and painful. As we get older, tissues become less flexible and the PF can become<br />

strained from something as simple as walking a full day in Disneyworld with non supporting, flat shoes.<br />

Although most people have heel pain that lasts only a couple of days, many have repeated episodes of PF<br />

strain leading to the development of scar tissue in the plantar fascia. It is thought that this scar tissue is the<br />

cause of chronic heel pain also known as plantar fasciosis. Although heel spurs (a small forward projection<br />

of bone under the heel) are related to plantar fasciitis, research has shown that permanent elimination of<br />

heel pain caused by plantar fascioses does NOT require the removal of the heel spur.<br />

> Plantar fasciitis is diagnosed with the classic symptoms of pain well localized over the heel area of the<br />

bottom of the foot. Often the pain from plantar fasciitis is most severe when you first stand on your feet in<br />

the morning. Pain often subsides quite quickly, but then returns after prolonged standing or walking.<br />

<br />

> Plantar fasciitis is most often seen in middle-aged men and women, but can be found in all age<br />

groups. The condition can be seen in people with high arches, normal arches, and flatfeet. Activities that<br />

seem to initiate PF are people who change their heel height on shoes from normal to flat heels; walking or<br />

running on a soft surface with non supporting shoes; taking on an exercise program and doing too much,<br />

too fast, and standing for long periods of time on a hard surface.<br />

> Plantar fasciitis is sometimes, but not always, associated with overweight people. It is sometimes seen<br />

in recreational athletes, especially runners. In these athletes, it is thought that the repetitive nature of the<br />

sport causes damage to the tissue at the attachment of the PF to the heel.<br />

> Symptoms of plantar fasciitis are typically worsened early in the morning after sleep. At that time, the<br />

arch tissue is tight and simple movements stretch the contracted tissue. As you begin to loosen the foot, the<br />

pain usually subsides, but often returns with prolonged standing or walking.


“<br />

The Weil Foot & Ankle Institute has been involved with Extracorporeal<br />

Shockwave Therapy (ESWT) since 2000 and was the first group in the USA<br />

to publish the results of this treatment for plantar fasciosis. Since that time,<br />

I have been the principal investigator on three FDA studies using different<br />

ESWT technologies (electrohydraulic, piezoelectric, and pneumatic technology<br />

– <strong>Swiss</strong> <strong>DolorClast</strong> ® ). Much to our surprise, the double blinded results of the <strong>Swiss</strong><br />

<strong>DolorClast</strong> ® superseded the results of the other two technologies while offering<br />

a tolerable treatment, over three sessions, without the use of sedation or even local anesthetic.<br />

We believe that ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® will be an important addition to treatment<br />

of the podiatric, orthopaedic, and sports medicine patients. ”<br />

<br />

“<br />

We had excellent experiences with the <strong>Swiss</strong> <strong>DolorClast</strong> ® , and I can fully recommend it. It is a<br />

valuable part of a modern treatment concept. Through(out) our international network, we have treated<br />

many professional athletes, and in no time they were all back in the game thanks to this non-invasive and<br />

gentle treatment.<br />

The medical community has only just begun to discover the possibilities of this treatment. ”<br />

<br />

<br />

“<br />

The Institute of Biomechanics and <strong>Ortho</strong>paedics of the German Sport<br />

University Cologne has been working with Extracorporeal Shockwaves Therapy<br />

(ESWT) for several years, with respect to clinical applications as well as basic<br />

research concerning its effects on a cellular level.<br />

During my personal experience with the <strong>Swiss</strong> <strong>DolorClast</strong> ® as the attending<br />

medical professional of ATP tennis players, I have observed an increased relevance<br />

of this therapy in the field of sports medicine and in the care of professional athletes.<br />

Based on our clinical application and various experimental research projects, extracorporeal<br />

shockwaves seem to be a successful and simple form of therapy for orthopaedic disorders. ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


“<br />

The <strong>Ortho</strong>Trauma Clinic has investigated safety and effectiveness of<br />

repetitive low-energy shock wave treatment without local anaesthesia for patients<br />

with chronic plantar fasciopathy (plantar heel pain).<br />

ESWT with the <strong>Swiss</strong> <strong>DolorClast</strong> ® device was effective in about 60%<br />

of cases. No rupture of the plantar fascia occurred, no side effects with the<br />

exception of bruising were recorded.<br />

Extracorporeal Shockwave Therapy (ESWT) is an important addition to<br />

treatment options for patients with recalcitrant plantar fasciopathy. ”<br />

<br />

<br />

“<br />

Heel pain can become a “chronic disease” which has a negative effect on a<br />

patient’s quality of life. Since the results of surgery are not guaranteed, extracorporeal<br />

shockwave therapy with the <strong>Swiss</strong> <strong>DolorClast</strong> ® provides an attractive alternative for<br />

the treatment of chronic heel pain syndrome. I am impressed by the high success rate<br />

and lack of complications in our study patients. ”<br />

<br />

“<br />

<strong>Swiss</strong> <strong>DolorClast</strong> ® is our permanent companion on ATP’s tennis tournaments and has become<br />

increasingly popular with players. ”<br />

<br />

<br />

<br />

“<br />

For plantar fasciitis the dolorclast system is incredibly convenient for doctor<br />

and patient. No need for anesthesia. “On the spot” in office delivery of therapeutic<br />

shockwaves. Safe, effective and well tolerated.<br />

Everyone should have one! ”


*<br />

<br />

<br />

<br />

<br />

<br />

<br />

> The number of potential patients is very high.<br />

> Anyone who suffers from chronic heel pain may be treated with the <strong>Swiss</strong> <strong>DolorClast</strong> ® method.<br />

> It is a proven alternative to surgery.<br />

> It offers a new and promising alternative to patients who are surgery candidates or are resigned to<br />

their condition and no longer seek therapy.<br />

> Today, many more patients are able to afford Extracorporeal Shockwave Therapy because compared<br />

to other methods the <strong>Swiss</strong> <strong>DolorClast</strong> ® method is much more economical.<br />

<br />

Patients per month<br />

x<br />

Applications per patient<br />

<br />

Total applications<br />

x<br />

Charge per application<br />

<br />

Monthly revenue


Display desired impulse count per treatment<br />

Display current impulse count<br />

Display operating frequency<br />

Increase impulse count per treatment<br />

Reduce impulse count per treatment<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Increase operating frequency<br />

Reduce operating frequency<br />

On/Off with indicator light<br />

Handpiece connection<br />

“Select” to activate change in preset impulse count<br />

“Validate” to confirm setting<br />

Single-impulse operation<br />

Continuous impulse operation<br />

Manometer for operating pressure<br />

<br />

Operating pressure regulator<br />

Handpiece<br />

Cable holder<br />

Bottle holder (gel)<br />

Drawer<br />

Compressor compartment


Electro Medical Systems (EMS) has been setting standards in the development and production of medical<br />

devices since 1981. Each product is individually produced and tested in Switzerland – with <strong>Swiss</strong> precision.<br />

> EMS is one of the world’s leading manufacturers of prophylactic dental devices.<br />

> With over 8,000 <strong>Swiss</strong> LithoClast ® devices in daily use, EMS is the world’s largest supplier<br />

of intracorporeal shockwave lithotriptors for the treatment of kidney, ureteric and bladder stones.<br />

> With its patented <strong>Swiss</strong> <strong>DolorClast</strong> ® , EMS offers products that benefit from the expertise and EMS<br />

offers a product defined experience with pneumatically generated shockwaves. Since its market introduction<br />

in 1999, <strong>Swiss</strong> <strong>DolorClast</strong> ® has been the reference for successful pain therapy and has made EMS the number<br />

one in Shockwave Therapy.<br />

> Like all EMS products, <strong>Swiss</strong> <strong>DolorClast</strong> ® meets the highest European and international<br />

quality standards.<br />

> Product certification: FDA Class III Medical Device, ISO 9001, ISO 13485 (Medical Devices),<br />

and CE Mark.<br />

> EMS is a promoting member of the ISMST (International Society for Musculoskeletal Shockwave<br />

Therapy), an official member of DIGEST (German and International Society for Extracorporeal Shockwave<br />

Therapy) and supports ATRAD (Association for Radial Pain Therapy).


CAUTION! Federal law restricts this device to sale by or on the order of a physician.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!